Skip to content

Clinical Effect of Fu's Subcutaneous Needling Targeting the Enteric Nervous System on Patients with Chronic Constipation and Its Influence on Neurotransmitters NO and SP

Clinical Effect of Fu's Subcutaneous Needling Targeting the Enteric Nervous System on Patients with Chronic Constipation and Its Influence on Neurotransmitters NO and SP

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000628
Enrollment
Unknown
Registered
2026-03-19
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Constipation

Interventions

Fu's Subcutaneous Needling Treatment Group:Fu's Subcutaneous Needling Treatment
Control Group:Oral Bifidobacterium Triple Viable Capsules

Sponsors

Chengdu Longquanyi District Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria for functional constipation in **Rome IV**. (2) Clinical manifestations of constipation that cannot be explained by organic, metabolic, or systemic diseases. (3) Age of the patients ranges from **18 to 80 years old**. (4) Patients provide **informed consent**, are willing to undergo relevant examinations, and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Patients with severe complications, such as intestinal paralysis, intestinal perforation, intestinal obstruction, and megacolon. (2) Patients with mental illness or severe neurological deficits (e.g., aphasia, agnosia), or with suspected or confirmed alcohol or drug abuse. (3) Patients with severe cardiovascular, pulmonary, hepatic, renal, hematological or other systemic diseases. (4) Patients with a history of abdominal trauma or surgery that may cause constipation. (5) Pregnant or lactating women. (6) Patients participating in other clinical research studies at the same time.

Design outcomes

Primary

MeasureTime frame
Evaluation Criteria for Therapeutic Effect of Traditional Chinese Medicine Syndromes;International Chronic Constipation Symptom Score;

Secondary

MeasureTime frame
Substance P;Nitric Oxide;

Countries

China

Contacts

Public ContactRong Lin

Chengdu Longquanyi District Hospital of Traditional Chinese Medicine

872100177@qq.com15196618186

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Apr 4, 2026